Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften Toetsvragen Web-tv Video Audio
Tips voor Mijn BSL
Inloggen

Welkom bij Scalda & Bohn Stafleu van Loghum

Scalda heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen.Je kunt de producten hieronder links aanschaffen en rechts inloggen.

» Andere revante producten voor Scalda studenten en medewerkers.

Registreer

Schaf de BSL Academy aan: 

BSL Academy mbo AG

Eenmaal aangeschaft kun je thuis, of waar ook ter wereld toegang krijgen tot Mijn BSL.

Heb je een vraag, neem dan contact op met Jan van der Velden.

Login

Als u al geregistreerd bent, hoeft u alleen maar in te loggen om onbeperkt toegang te krijgen tot Mijn BSL.

Inloggen
Top
Quality of Life Research
Gepubliceerd in:

08-03-2018

Life for patients with myelofibrosis: the physical, emotional and financial impact, collected using narrative medicine—Results from the Italian ‘Back to Life’ project

Auteurs: Francesca Palandri, Giulia Benevolo, Alessandra Iurlo, Elisabetta Abruzzese, Angelo M. Carella, Chiara Paoli, Giuseppe A. Palumbo, Massimiliano Bonifacio, Daniela Cilloni, Alessandro Andriani, Attilio Guarini, Diamante Turri, Elena Maria Elli, Antonietta Falcone, Barbara Anaclerico, Pellegrino Musto, Nicola Di Renzo, Mario Tiribelli, Renato Zambello, Caterina Spinosa, Alessandra Ricco, Letizia Raucci, Bruno Martino, Mario Annunziata, Silvia Pascale, Anna Marina Liberati, Giorgio La Nasa, Margherita Maffioli, Massimo Breccia, Novella Pugliese, Silvia Betti, Gianfranco Giglio, Antonietta Cappuccio, Luigi Reale

Gepubliceerd in: Quality of Life Research | Uitgave 6/2018

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

Myelofibrosis (MF) is a chronic myeloproliferative neoplasm characterised by an aggressive clinical course, with disabling symptoms and reduced survival. Patients experience a severely impaired quality of life and their families face the upheaval of daily routines and high disease-related financial costs. The aim of this study was to investigate the perceptions of Italian patients and their caregivers about living with MF and the burden of illness associated with MF.

Methods

A quali-quantitative questionnaire and a prompted written narrative survey were administered to patients affected by primary or post-essential thrombocythemia/post-polycythaemia vera MF and their primary caregiver in 35 Italian haematological centres.

Results

In total, 287 questionnaires were returned by patients and 98 by caregivers, with 215 and 62, respectively, including the narrative. At the time of diagnosis, the most commonly expressed emotional states of patients were fear, distress and anger, confirming the difficulty of this phase. A high level of emotional distress was also reported by caregivers. Along the pathway of care, the ability to cope with the disease differed according to the quality of care received. The mean cost to each patient attributable to MF was estimated as €12,466 per year, with an estimated average annual cost of loss of income of €7774 per patient and €4692 per caregiver.

Conclusions

Better understanding of the personal life of MF patients and their families could improve the relationships between health workers and patients, resulting in better focused healthcare pathways and more effective financial support to maintain patients in their social roles.
vorige artikel Survivorship care plans have a negative impact on long-term quality of life and anxiety through more threatening illness perceptions in gynecological cancer patients: the ROGY care trial
volgende artikel Effects of treatment, choice, and preference on health-related quality-of-life outcomes in patients with posttraumatic stress disorder (PTSD)
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
Smith, R. E., Chelmowski, M. K., & Szabo, E. J. (1990). Myelofibrosis: A review of clinical and pathologic features and treatment. Critical Reviews in Oncology/Hematology, 10, 305.CrossRefPubMed
2.
Campbell, P. J., & Green, A. R. (2006). The myeloproliferative disorders. The New England Journal of Medicine, 355, 2452.CrossRefPubMed
3.
Lataillade, J. J., Pierre-Louis, O., Hasselbalch, H. C., et al. (2008). Does primary myelofibrosis involve a defective stem cell niche? From concept to evidence. Blood, 112, 3026.CrossRefPubMed
4.
Mesa, R. A., Verstovsek, S., & Cervantes, F. (2007). Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): Consensus on terminology by the international working group for myelofibrosis research and treatment (IWG-MRT). Leukemia Research, 31(6), 737–740.CrossRefPubMed
5.
Ciurea, S. O., Merchant, D., Mahmud, N., et al. (2007). Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis. Blood, 110, 986.CrossRefPubMedPubMedCentral
6.
Tefferi, A. (2005). Pathogenesis of myelofibrosis with myeloid metaplasia. Journal of Clinical Oncology, 23, 8520.CrossRefPubMed
7.
8.
Moulard, O., Mehta, J., Fryzek, J., et al. (2014) Epidemiology of myelofibrosis, essential thrombocythemia, and polycythemia vera in the European Union. European Journal of Hematology, 92(4), 289–297.CrossRef
9.
Komrokji, R. S., Verstovsek, S., Padron, E., et al. (2012) Advances in the management of myelofibrosis. Cancer Control. 19(4 Suppl), 4–15.CrossRefPubMed
10.
Mesa, R. A. (2010). Assessing new therapies and their overall impact in myelofibrosis. Hematology Am Soc Hematol Educ Program, 2010, 115–121.PubMed
11.
Gupta, V., Malone, A. K., Hari, P. N., et al. (2014). Reduced- intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant research. Biology of Blood Marrow Transplant, 20(1), 89–97.CrossRef
12.
Scherber, R. M., Geyer, H. L., & Mesa, R. A. (2014). Quality of life in MPN comes of age as a therapeutic target. Current Hematologic Malignancy Reports, 9(4), 324–330.CrossRefPubMed
13.
Verstovsek, S., Kantarjian, H., Mesa, R. A., et al. (2010). Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis. The New England Journal of Medicine, 363(12), 1117–1127.CrossRefPubMedPubMedCentral
14.
Steensma, D. P., Heptinstall, K. V., Johnson, V. M., et al. (2008) Common troublesome symptoms and their impact on quality of life in patients with myelodysplastic syndromes (MDS): Results of a large internet-based survey. Leukemia Research, 32(5), 691–698.CrossRefPubMed
15.
Johansson, P., Mesa, R., Scherber, R., et al. (2012). Association between quality of life and clinical parameters in patients with myeloproliferative neoplasms. Leukemia & Lymphoma, 53(3), 441–444.CrossRef
16.
17.
18.
Hurwitz, B., Greenhalgh, T., & Skultans, V. Narrative research in health and illness. London: British Medical Association Ed (2004).CrossRef
19.
Greenhalgh, T., & Hurwitz, B. (1998). Why study narrative? In T. Greenhalgh & B. Hurwitz (Eds.), Narrative based medicine: dialogue and discourse in clinical practice (pp. 3–16). London: British Medical Journal Books.
20.
21.
DasGupta, S., & Charon, R. (2004). Personal illness narratives: Using reflective writing to teach empathy. Academic Medicine, 79, 4.CrossRef
22.
Kleinman, A. (1988). The illness narratives: Suffering, healing, and the human condition. New York: Basic books.
23.
Marini, M. G., & Arreghini, L. (2012). Narrative medicine for a sustainable healthcare system. Milano: Lupetti.
24.
Marini, M. G. (2016). Narrative medicine: Bridging the gap between evidence-based care and medical humanities. London: Springer International Publishing.CrossRef
25.
Tarricone, R. (2006). Cost-of-illness analysis. What Room in Health Economics? Health Policy, 77, 51–63.PubMed
26.
Pieri, L., Loiacono, I., & Vannucchi, A. M. (2013). The burden of symptoms in myelofibrosis: From patient-reported outcomes to health economics. Leukemia Research, 37(8), 855–856.CrossRefPubMed
27.
Personal data code protection. (2003). Law 30/06/2003 n.196. Published on the Italian Official Journal n.174., 29th July 2003, Supplementary n.123.
28.
Epstein-Lubow, G., Gaudiano, B. A., Hinckley, M., et al. (2010). Evidence for the validity of the American Medical Association’s Caregiver Self-Assessment Questionnaire as a screening measure for depression. Journal of American Geriatric Society, 58(2), 387–388.CrossRef
29.
Corbin, J., & Strauss, A. (2015) Basics of qualitative research. Techniques and procedures for developing Grounded Theory. Los Angeles: SAGE Publications.
30.
Bazeley, P., & Jackson, K. (2013) Qualitative Data Analysis with NVivo (pp. 68–73). London: Sage.
31.
Launer, J. (2006). New stories for old: Narrative-based primary care in Great Britain. Families, Systems and Health, 24(3), 336–344.CrossRef
32.
Weiten, W., & Lloyd, M. A. (2008) Psychology applied to modern life. (9th edn.). Boston, MA: Wadsworth Cengage Learning
33.
Carver, C. S., et al. (1989). Assessing coping strategies: A theoretically based approach. Journal of Personality and Social Psychology, 56(N.2), 267–283.CrossRefPubMed
34.
Heather, N., Rasmussen, C., Wrosch, M. F., Scheier, & Carver, C. S. (2006). Self-regulation processes and health: The importance of optimism and goal adjustment. Journal of Personality, 74(6), 1721–1748.CrossRef
35.
Carver, C. S., & Connor-Smith, J. (2010). Personality and coping. Annual Review of Psychology, 61, 679–704.CrossRefPubMed
36.
Kennedy, T. J., & Lingard, L. A. (2006). Making sense of grounded theory in medical education. Medical Education, 40, 101–108.CrossRefPubMed
37.
38.
39.
40.
41.
42.
Istat. (2012). Annuario statistico italiano.
43.
Gimenez, E., Besses, C., Boque, C., et al. (2014). Indirect and non-medical economic burden, quality-of-life, and disabilities of the myelofibrosis disease in Spain. Journal of Medical Economics, 17(6), 435–441.CrossRefPubMed
44.
Mesa, R., Miller, C. B., Thyne, M., Mangan, J., Goldberger, S., et al. (2014). Gaps in perception between patients and physicians regarding symptomatology and treatment attitudes for myeloproliferative neoplasms: MPN LANDMARK SURVEY. Blood, 24, 4827.
45.
Robin Yabroff, K., Lawrence, W. F., Clauser, S., Davis, W. W., & Brown, M. L. (2004). Burden of illness in cancer survivors: Findings from a population-based national sample. Journal of the National Cancer Institute, 96(17), 1322–1330.
46.
Ayres, L. (2000) Narratives of family caregiving: Four story types. Research in Nursing and Health, 23, 359–371.CrossRefPubMed
47.
Levit Laura, A., et al. (Eds.). (2013). Patient-centered communication and shared decision making. In Delivering high-quality cancer care: Charting a new course for a system in crisis. Washington, DC: National Academies Press.
48.
Sklenarova, H., et al. (2015). When do we need to care about the caregiver? Supportive care needs, anxiety, and depression among informal caregivers of patients with cancer and cancer survivors. Cancer, 121(9), 1513–1519.CrossRefPubMed
Metagegevens
Titel
Life for patients with myelofibrosis: the physical, emotional and financial impact, collected using narrative medicine—Results from the Italian ‘Back to Life’ project
Auteurs
Francesca Palandri
Giulia Benevolo
Alessandra Iurlo
Elisabetta Abruzzese
Angelo M. Carella
Chiara Paoli
Giuseppe A. Palumbo
Massimiliano Bonifacio
Daniela Cilloni
Alessandro Andriani
Attilio Guarini
Diamante Turri
Elena Maria Elli
Antonietta Falcone
Barbara Anaclerico
Pellegrino Musto
Nicola Di Renzo
Mario Tiribelli
Renato Zambello
Caterina Spinosa
Alessandra Ricco
Letizia Raucci
Bruno Martino
Mario Annunziata
Silvia Pascale
Anna Marina Liberati
Giorgio La Nasa
Margherita Maffioli
Massimo Breccia
Novella Pugliese
Silvia Betti
Gianfranco Giglio
Antonietta Cappuccio
Luigi Reale
Publicatiedatum
08-03-2018
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 6/2018
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-018-1827-2

Andere artikelen Uitgave 6/2018

How does age affect the relationship between weight and health utility during the middle years of childhood?

  • Open Access

Longitudinal and dynamic measurement invariance of the FACIT-Fatigue scale: an application of the measurement model of derivatives to ECOG-ACRIN study E2805

Human development index, children’s health-related quality of life and movement behaviors: a compositional data analysis

Measurement properties of depression questionnaires in patients with diabetes: a systematic review

  • Open Access
  • Review

Manual lymphatic drainage and quality of life in patients with lymphoedema and mixed oedema: a systematic review of randomised controlled trials

  • Open Access
  • Review

Differential item functioning for items in Berger’s HIV Stigma Scale: an analysis of cohorts from the Indian, Swedish, and US contexts

  • Open Access